phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Seragon Publishes Data for Longevity Drug Srn-901 Showing Significant Lifespan and Healthspan Extension

Seragon Biosciences Inc. today announced the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development and Therapy, demonstrating that its investigational combinatorial longevity drug, SRN-901, significantly extended median remaining lifespan and attenuated frailty progression in adult mice.

April 15, 2026


April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy